For many years we have been working conscientiously and with the most diverse technologies and means. We have constantly successfully completed our projects. We believe that the full benefits and potential of cannabis as a medical therapy are within our reach only through supply chain transparency, an engaged and active network of cannabis users, and data that is consistently available and verifiable for medical surveys and for developing and establishing therapies and life-prolonging solutions and treatments on blockchain technology. Our vision is one in which cannabis medical research gets the support it needs and deserves.
The global medical marijuana market is projected to grow at an annualized rate of almost 18% through 2028, according to Data Bridge Market Research. Much of this growth will likely be in the U.S., where 37 states have already legalized medical cannabis. Medical cannabis products sold in the U.S. include dried flower, vaping concentrates, cannabis-infused edibles, and topical products such as lotion.
Investors who opt to buy individual medical marijuana stocks can choose among Canadian or U.S. companies. Canadian medical cannabis companies can legally list on U.S. stock exchanges, while U.S. medical cannabis companies operating legally at the state level can legally list on Canadian stock exchanges and over the counter (OTC).